Thrombopoietin-receptor agonist as a treatment of thrombocytopenia associated with systemic lupus erythematosus
Reumatol Clin. 2016 Jan-Feb;12(1):57.
doi: 10.1016/j.reuma.2015.04.004.
Epub 2015 May 27.
[Article in
English,
Spanish]
Affiliations
- 1 Reumatología, Hospital Universitario Rafael Méndez, Lorca, Murcia, España. Electronic address: mjmorenomartinez@gmail.com.
- 2 Hematología, Hospital Universitario Rafael Méndez, Lorca, Murcia, España.
- 3 Reumatología, Hospital Universitario Virgen de la Arrixaca, Murcia, España.
No abstract available
MeSH terms
-
Adult
-
Benzoates / therapeutic use*
-
Female
-
Humans
-
Hydrazines / therapeutic use*
-
Lupus Erythematosus, Systemic / complications*
-
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
-
Purpura, Thrombocytopenic, Idiopathic / etiology
-
Pyrazoles / therapeutic use*
-
Receptors, Thrombopoietin / antagonists & inhibitors*
Substances
-
Benzoates
-
Hydrazines
-
Pyrazoles
-
Receptors, Thrombopoietin
-
eltrombopag